Pioglitazone for Secondary Prevention after Ischemic Stroke and Transient Ischemic Attack: Rationale and Design of the Insulin Resistance Intervention after Stroke (IRIS) Trial

BACKGROUND: Recurrent vascular events remain a major source of morbidity and mortality after stroke or transient ischemic attack (TIA). The Insulin Resistance Intervention after Stroke (IRIS) trial is evaluating an approach to secondary prevention based on the established association between insulin...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Am Heart J
Main Authors: Viscoli, Catherine M., Brass, Lawrence M., Carolei, Antonio, Conwit, Robin, Ford, Gary A., Furie, Karen L., Gorman, Mark, Guarino, Peter D., Inzucchi, Silvio E., Lovejoy, Anne M., Parsons, Mark W., Peduzzi, Peter N., Ringleb, Peter, Schwartz, Gregory G., Spence, J. David, Tanne, David, Young, Lawrence H., Kernan, Walter N.
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4254508/
https://ncbi.nlm.nih.gov/pubmed/25458644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2014.07.016
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker